Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice.

by Hien T Tran, Laura Sanchez, Thomas J Esparza, David L Brody
Published 2011-01-01

Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease

by David L. Brody, Hao Jiang, Norelle Wildburger, Thomas J. Esparza
Published 2017-08-01

Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.

by Thomas J Esparza, Mihika Gangolli, Nigel J Cairns, David L Brody
Published 2018-01-01

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme

by Thomas J. Esparza, Negin P. Martin, George P. Anderson, Ellen R. Goldman, David L. Brody
Published 2020-12-01

Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method

by Shiran Su, Thomas J. Esparza, Duong Nguyen, Simone Mastrogiacomo, Joong H. Kim, David L. Brody
Published 2021-08-01

Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study

by Katherine E. Schwetye, John R. Cirrito, Thomas J. Esparza, Christine L. Mac Donald, David M. Holtzman, David L. Brody
Published 2010-12-01

Sensitive detection of extremely small iron oxide nanoparticles in living mice using MP2RAGE with advanced image co-registration

by Joong H. Kim, Stephen Dodd, Frank Q. Ye, Andrew K. Knutsen, Duong Nguyen, Haitao Wu, Shiran Su, Simone Mastrogiacomo, Thomas J. Esparza, Rolf E. Swenson, David L. Brody
Published 2021-01-01